News Website

Richter signs endometriosis antibody deal - FemTech World

Richter signs endometriosis antibody deal FemTech World

Published: Feb. 19, 2026, 2:03 p.m.

Read Full Article

Japanese pharmas team up on AI-led gynaecology drug research - FemTech World

Japanese pharmas team up on AI-led gynaecology drug research FemTech World

Published: Feb. 19, 2026, 1:03 p.m.

Read Full Article

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination - FemTech World

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination FemTech World

Published: Feb. 19, 2026, 9:02 a.m.

Read Full Article

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.

Read Full Article

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.

Read Full Article

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.

Read Full Article

Singapore start-up raises US$1.5m to redefine menstrual health - FemTech World

Singapore start-up raises US$1.5m to redefine menstrual health FemTech World

Published: Feb. 16, 2026, 2:50 p.m.

Read Full Article

‘I thought it was depression’: How PMDD was misdiagnosed - and the FemTech revolution changing women’s health - The Independent

‘I thought it was depression’: How PMDD was misdiagnosed - and the FemTech revolution changing women’s health The Independent

Published: Feb. 16, 2026, 7 a.m.

Read Full Article

‘I thought my PMDD was depression - How Femtech revolution is changing women’s health - The Independent

‘I thought my PMDD was depression - How Femtech revolution is changing women’s health The Independent

Published: Feb. 16, 2026, 7 a.m.

Read Full Article

A Previous History of Endometriosis Elevates Irritable Bowel Syndrome Risk in Middle-Aged and Older Women: A UK Biobank Cohort Study of 225,703 Participants.

Endometriosis (EMT) and irritable bowel syndrome (IBS) disproportionately affect middle-aged and older women, where overlapping symptoms (e.g., chronic pelvic pain, bloating) and shared inflammatory mechanisms may drive comorbidity. However, large-scale …

Published: Feb. 16, 2026, midnight

Read Full Article

Endometriosis Epidemiology Irritable bowel syndrome UK biobank

Latest Articles

Richter signs endometriosis antibody deal - FemTech World

Japanese pharmas team up on AI-led gynaecology drug research - FemTech World

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination - FemTech World

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Singapore start-up raises US$1.5m to redefine menstrual health - FemTech World

‘I thought it was depression’: How PMDD was misdiagnosed - and the FemTech revolution changing women’s health - The Independent

‘I thought my PMDD was depression - How Femtech revolution is changing women’s health - The Independent

A Previous History of Endometriosis Elevates Irritable Bowel Syndrome Risk in Middle-Aged and Older Women: A UK Biobank Cohort Study of 225,703 Participants.

Subscribe to Our Newsletter